"10.1371_journal.pone.0121429","plos one","2015-03-27T00:00:00Z","Wei Huang; Frederick A Anderson; Sophie K Rushton-Smith; Alexander T Cohen","Center for Outcomes Research, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America; Department of Haematological Medicine, Guys and St Thomas NHS Foundation Trust, Kingâ€™s College, London, United Kingdom","Conceived and designed the experiments: WH FA ATC. Analyzed the data: WH. Contributed reagents/materials/analysis tools: WH. Wrote the paper: WH FA SRS ATC.","Wei Huang: sanofi. Frederick A. Anderson Jr.: has received research grants from sanofi-aventis and The Medicines Company. He has served as a consultant to GSK and Millennium on the design of outcomes studies. Sophie K. Rushton-Smith: consultancy for Bayer, Sanofi, Boehringer-Ingelheim and Bristol-Myers Squibb. Alexander T. Cohen: Dr. A. T. Cohen is a medical consultant, and has received consultancy and clinical trial funding from many pharmaceutical companies, including Bayer, Boehringer-Ingelheim, BMS, Daiichi, GSK, Johnson and Johnson, Mitsubishi Pharma, Pfizer, Portola, sanofi-aventis, Schering Plough, and Takeda. He is an advisor to the UK Government Health Select Committee, the all-party working group on thrombosis, the Department of Health, and the NHS, on the prevention of VTE. He is also an advisor to Lifeblood: the thrombosis charity and is the founder of the European educational charity the Coalition to Prevent Venous Thromboembolism. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","03","Wei Huang","WH",4,TRUE,3,NA,1,4,TRUE,TRUE,FALSE,0,NA,FALSE
